Startup Professionals Musings
AUGUST 4, 2014
The first question I usually get is what percent of the company or equity is that person worth? Just because it was your idea doesn’t mean you “deserve” 90 percent of the equity. The value in a startup is all about tangible results, so there is no equity value in the idea alone. Key to required patents or trade secrets.
Startup Professionals Musings
OCTOBER 5, 2014
Deferred payments start with stretching the payables period but, more importantly, include giving employee equity in lieu of a higher salaries and negotiating vendor deferred payments out of future revenues. That should equate to an adequate valuation for a $2 million follow-on Series-A round, without giving away all the equity.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
JUNE 3, 2016
Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). —When Merck (NYSE: MRK ) bought Cubist Pharmaceuticals for $9.5
Startup Professionals Musings
JULY 30, 2014
In addition, we all know that patent disclosure rules often facilitate legal reverse engineering, and innovation at this point is now much cheaper. Most equity investors tend to avoid truly disruptive technology startups, since they take longer and more money to scale. Martin Zwilling First published on Entrepreneur.com on 7/21/2014.
socalTECH
DECEMBER 7, 2016
Eli Aizenstat: I entered into the Design Accelerator, which is an accelerator run in conjunction with the Art Center College of Design and Caltech, in the summer of 2014. Barry Lieberman: That funding round, which was a preferred seed equity round, took place in the summer of 2015, and there was $785,000 in the round. All are separate.
Expert insights. Personalized for you.
104 
Let's personalize your content